Vi­ro­Cell to op­er­ate from a Lon­don fa­cil­i­ty to man­u­fac­ture vi­ral vec­tors for clin­i­cal tri­als

Vi­ral vec­tor man­u­fac­tur­er Vi­ro­Cell Bi­o­log­ics is leas­ing its first-ever fa­cil­i­ty — lo­cat­ed at Great Or­mond Street Hos­pi­tal in Lon­don — so it can of­fer its ser­vices for clin­i­cal re­search.

Vi­ro­Cell worked with the hos­pi­tal for about 18 months to se­cure the GMP cer­tifi­cate for the Lon­don fa­cil­i­ty, which was grant­ed in Jan­u­ary this year, CEO John Had­den told End­points News in an in­ter­view. The vi­ral vec­tor li­cense was grant­ed two weeks ago.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER